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WNT signaling is required for embryonic
development, maintenance of stem cells
in an undifferentiated state, and homeo-
stasis of adult tissues. Here, Ross et al.
provide genetic evidence that this
signaling pathway is also essential to the
process of reprogramming of somatic
cells to an induced pluripotent state.
These studies also reveal an unexpected
link between aberrant WNT signaling
and chromosomal instability.
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WNT signaling promotes the reprogramming of
somatic cells to an induced pluripotent state. We
provide genetic evidence that WNT signaling is a
requisite step during the induction of pluripotency.
Fibroblasts from individuals with focal dermal hypo-
plasia (FDH), a rare genetic syndrome caused by
mutations in the essential WNT processing enzyme
PORCN, fail to reprogram with standard methods.
This blockade in reprogramming is overcome by
ectopic WNT signaling and PORCN overexpression,
thus demonstrating that WNT signaling is essential
for reprogramming. The rescue of reprogramming
is critically dependent on the level of WNT signaling:
steady baseline activation of the WNT pathway
yields karyotypically normal iPSCs, whereas daily
stimulation with Wnt3a produces FDH-iPSCs with
severely abnormal karyotypes. Therefore, although
WNT signaling is required for cellular reprogram-
ming, inappropriate activation of WNT signaling in-
duces chromosomal instability, highlighting the pre-
carious nature of ectopic WNT activation and its
tight relationship with oncogenic transformation.
INTRODUCTION
The process of converting, or reprogramming, a mature cell type
to an embryonic stem cell-like state requires the establishment
of a transcriptional regulatory network comprised of tran-
scription factors, including POU5F1/OCT4, SOX2, and NANOG
(Boyer et al., 2005; Cole et al., 2008). In human and mouse em-
bryonic stem cells, these factors maintain each other’s expres-
sion, and hence the pluripotent state, through regulatory feed-
back mechanisms. Disruption of this regulatory circuit causes
cells to exit the pluripotent state and differentiate. Extracellular
signals, such as FGF2 in human embryonic stem cells (hESCs)
and LIF in mouse embryonic stem cells, influence and regulate1770 Cell Reports 9, 1770–1780, December 11, 2014 ª2014 The Autthe pluripotent state. In addition, theWNT signaling pathway crit-
ically influences the pluripotent state of embryonic stem cells
(Blauwkamp et al., 2012; Jiang et al., 2013; Lyashenko et al.,
2011; Sato et al., 2004; ten Berge et al., 2011; Wray et al.,
2011; Yi et al., 2011). Although establishment of the OCT4-
NANOG-SOX2 transcriptional regulatory network is clearly crit-
ical for the generation of induced pluripotent stem cells (iPSCs),
the role of extracellular signals, such as WNTs, in this process
has not been examined extensively.
WNT and the WNT/b-catenin signaling pathway (also known
as the canonical WNT signaling pathway) have been implicated
in iPSC generation; however, significant controversy surrounds
their specific role in this process. First, in the original iPSC
studies, b-catenin was found to promote reprogramming; how-
ever, it was eliminated from the final reprogramming factor
cocktail (Takahashi and Yamanaka, 2006). Second, addition of
WNT proteins influences the induction of the pluripotent state
(Aulicino et al., 2014; Ho et al., 2013; Marson et al., 2008; Zhang
et al., 2014); however, one study found that WNT/b-catenin
signaling was stimulatory (Zhang et al., 2014), whereas other
studies found that it was inhibitory during early stages of re-
programming (Aulicino et al., 2014; Ho et al., 2013). Third, small
molecules that inhibit GSK3—and hence activate WNT/b-cate-
nin signaling—stimulate reprogramming efficiencies (Li et al.,
2009; Silva et al., 2008) and can promote reprogramming with
OCT4 as the only reprogramming factor (Li et al., 2011). How-
ever, GSK3 inhibitors, as well as purified WNT proteins, potently
promote mesendodermal differentiation of hESCs (Bakre et al.,
2007; Davidson et al., 2012), creating a conundrum over how
prodifferentiation factors can also promote the induction of
the pluripotent state. Finally, despite these established links
between WNT signaling and the generation of iPSCs, a strict
requirement for WNT signaling in this process has not been
demonstrated. In this study, we employ fibroblasts from pa-
tients harboring mutations in an essential WNT processing
enzyme, called PORCN, to establish that endogenous WNT
signaling is required during the process of inducing a pluripotent
stem cell state from fibroblasts.
The PORCN gene encodes an integral membrane-resident
endoplasmic reticulum protein that regulates processing ofhors
WNT proteins by catalyzing the covalent attachment of a lipid
moiety to the WNT polypeptide backbone (Barrott et al., 2011;
Biechele et al., 2011; Galli et al., 2007; Herr and Basler, 2012; Ka-
dowaki et al., 1996; Proffitt and Virshup, 2012; van den Heuvel
et al., 1993; Zhai et al., 2004). This lipid modification is essential
forWNT activity and, as demonstrated by the X-ray crystal struc-
ture of a WNT protein in complex with its receptor, is directly
involved in receptor binding (Janda et al., 2012). Given the high
degree of homology among members of the WNT gene family,
it is generally accepted that disruption of PORCN activity, either
bymutation or with small molecule inhibitors, impairs processing
of all WNT proteins. Therefore, PORCN dysfunction will produce
an ‘‘all-WNT’’ mutant phenotype.
Porcn knockout mice are early embryonic lethal and fail to
enter early stages of embryonic induction as indicated by the
absence of Bry/T expression at E6.5 (Barrott et al., 2011; Bie-
chele et al., 2011; Liu et al., 2012), a nearly identical phenotype
to that observed inWnt3 knockout mice (Liu et al., 1999). In hu-
mans, PORCN mutations lead to a rare pleiotropic disorder
called Focal Dermal Hypoplasia (FDH; also known as Goltz syn-
drome) (Grzeschik et al., 2007; Wang et al., 2007), characterized
by skin lesions and defects of the gastrointestinal, cardiovascu-
lar, and central nervous system (Temple et al., 1990). In affected
females, the severity of disease is influenced by the nature of the
PORCN mutation and the extent to which the mutant PORCN
allele is on the active X chromosome. Males carrying PORCN
mutations are rare and have acquired somatic mutations during
embryonic development and hence are mosaic with respect
to the PORCN mutation and PORCN function. Because the
mammalian genome encodes a single PORCN gene that specif-
ically modifies WNT proteins, it offers a natural bottleneck in
WNT processing to explore the requirement of WNT proteins in
any biological process.
In this study, we show that fibroblasts from individuals carrying
mutations in the PORCN gene fail to reprogram to an induced
pluripotent state. This blockade to iPSC formation is readily
overcome through the ectopic activation of WNT signaling or
by overexpression ofPORCN. Additionally, we show that precise
dosing of WNT activity is critical to generating karyotypically
normal iPSCs, an observation that has important implications
for WNT’s role in promoting genomic instability and hence in
cancer progression.
RESULTS
Focal dermal hypoplasia (FDH) is a rare genetic syndrome
with many pleiotropic consequences caused by mutations in
the X-linked gene PORCN. To study this complex disorder, we
sought to develop a disease-in-a-dish by first reprogramming
fibroblast cultures from FDH patients to iPSCs (Figure 1A). To
this end, we established fibroblast cultures from skin punch
biopsies from individuals with clinical hallmarks of FDH and
confirmed the presence of PORCN mutations by sequencing
(summarized in Table S1). One of the mutations (FDH2) altered
the highly conserved GT splice donor site after exon 2, allowing
us to demonstrate by RT- PCR that the fibroblast culture ex-
pressed undetectable to very low levels of the wild-type (WT)
PORCN gene (Figures S1A and S1B). Interestingly, in contrastCell Reto WT fibroblasts, FDH fibroblasts failed to yield iPSC colonies
(Figures 1B and 1C; Table S1). Because PORCN encodes an
essential WNT processing enzyme, we reasoned that a defect
in WNT secretion contributed to the observed reprogramming
defect. Consistent with this hypothesis, FDH fibroblasts (FDH2
and FDH3) failed to secrete WNT proteins at levels observed
for WT fibroblasts (an age-matched control FDH6 and FDH7),
as monitored by secretion of the WNT protein encoded by the
WNT5A gene (Figures S1C and S1D). (Note that other WNT pro-
teins may be secreted by WT cells; however, we do not currently
have a sensitive detection assay for other WNT proteins.) Treat-
ment of WT fibroblasts with the PORCN inhibitor IWP2 (IWP)
(Chen et al., 2009) greatly reduced levels of WNT5A protein in
the CM, confirming that WNT secretion is dependent on PORCN
function (Figure S1D).
Importantly, treatment with Wnt3a after transduction of the
reprogramming factors restored iPSC generation from FDH
fibroblasts (Figures 1B and 1C; Table S1), suggesting that
endogenous WNT secretion and signaling are required during
the process of reprogramming from a fibroblast to an iPSC. Re-
programming of FDH fibroblasts required exogenous Wnt3a
regardless of whether MYC, a known WNT/b-catenin target in
several cell types (He et al., 1998; Zhang et al., 2012), was
included as one of the reprogramming factors (KMOS versus
KOS; Table S1). The fact that inclusion of MYC as a reprogram-
ming factor fails to yield FDH-iPSCs indicates that transcriptional
activation of MYC by WNT is insufficient in promoting reprog-
ramming and that other downstream WNT targets are involved.
In addition, we found that a GSK3 inhibitor, CHIR98014 (CHIR),
rescued FDH fibroblast reprogramming (Table S1), suggesting
thatWNT acts through the stabilization of its keymediator, b-cat-
enin. These data indicate that WNT acts through b-catenin (i.e.,
the canonical WNT pathway) to promote reprogramming to the
induced pluripotent state.
The observation that exogenous Wnt3a rescues reprogram-
ming of FDH fibroblasts implies that the mutant PORCN pro-
tein fails to properly process endogenously expressed WNT
proteins. To address this point, we transduced a PORCN trans-
gene along with the KMOS reprogramming factors. As ex-
pected, overexpression of PORCN, like ectopic Wnt3a treat-
ment, rescued the reprogramming defect of FDH fibroblasts
(Figures 1D and 1E). Isolated PORCN-rescued FDH iPSCs car-
ried the PORCN transgene (Figure S1E). Therefore, in FDH fibro-
blasts, PORCN is an essential reprogramming factor, along with
KMOS.
Consistent with this genetic evidence that PORCN function is
required for reprogramming, we found that treatment of WT
fibroblast cultures undergoing standard reprogramming assays
with the PORCN inhibitor IWP significantly reduced the number
alkaline phosphatase-positive (AP+) colonies (Figure 1F). This
reduction in reprogramming rates was previously reported by
others (Ho et al., 2013). As with FDH fibroblasts, this blockade
on reprogramming was overcome by addition of exogenous
Wnt3a protein, suggesting that PORCN processing of endo-
genously produced WNT proteins is required for cellular
reprogramming.
Isolation and expansion of iPSC colonies generated from
FDH fibroblasts required continuous ectopic stimulation ofports 9, 1770–1780, December 11, 2014 ª2014 The Authors 1771
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Figure 1. Ectopic WNT Signaling and PORCN Overexpression Restores Reprogramming of PORCN Mutant Fibroblasts
(A) Flow chart of reprogramming experiments. Fibroblast cultures established from unaffected and affected FDH individuals were transduced with re-
programming factors (KLF4,MYC,OCT4, and SOX2 [KMOS] or KLF4,OCT4, and SOX2 [KOS]) via viral infections with either retro- (RV), lenti- (LV) or Sendai-viral
(SV) vectors. After passaging to hESC culture conditions, culture media were supplemented with compounds that perturb WNT signaling. Once colonies were
visible by eye, cultures were fixed and stained for Alkaline Phosphatase (AP) to quantify colony numbers per condition or individual colonies were isolated and
expanded as iPSC lines.
(B) PORCN mutant fibroblasts (FDH2 and 3) fail to reprogram in the absence of exogenous WNT activation. Addition of Wnt3a during reprogramming restores
generation of AP+ colonies. Buffer, WNT storage buffer. Shown are representative images of AP-stained cultures. Scale bar represents 10 mm.
(C) Quantitation of reprogramming experiments in FDH fibroblasts. (Mean ± SD of four biological replicates for WT and of three biological replicates for FDH2
and 3.)
(D) Overexpression of PORCN in FDH3 fibroblasts, as well as treatment with the GSK3 inhibitor CHIR98014 (CHIR), rescues the reprogramming defect of PORCN
mutant cells. Scale bar represents 10 mm.
(E) Quantitation of reprogramming experiments in FDH fibroblasts. (Mean ± SD of three biological replicates for FDH3.)
(F) A PORCN inhibitor blocks reprogramming. Fibroblasts undergoing reprogramming in the presence of the PORCN inhibitor IWP fail to yield AP-positive (AP+)
colonies. This inhibitory effect is overcome by addition of Wnt3a protein. (Mean ± SD of three biological replicates. **p < 0.005; ***p < 0.001.)
See also Figure S1 and Table S1.WNT signaling. When cultured in media containing CHIR at
low concentrations (20 nM), FDH-iPSCs expressed the plurip-
otency markers NANOG and POU5F1/OCT4 at levels compa-
rable to WT iPSCs (Figure 2A). In the absence of CHIR,
NANOG and POU5F1/OCT4 expression levels were unaffected
in WT iPSCs but decreased in FDH-iPSCs, indicating that
an endogenous WNT signaling loop maintains optimal expres-
sion levels of these pluripotency regulators. As expected, at
high CHIR concentrations (200 to 1,000 nM), NANOG and
POU5F1/OCT4 expression levels declined dramatically, indic-
ative of cells exiting the pluripotent state. In addition, in the1772 Cell Reports 9, 1770–1780, December 11, 2014 ª2014 The Autpresence of low CHIR concentrations (20 nM), FDH-iPSCs dis-
played morphologies most closely resembling those of human
pluripotent stem cells (Figure 2B). Withdrawal of CHIR from
FDH-iPSCs led to marked reduction in cell-surface staining
of the pluripotency markers SSEA4 and TRA1-81 (Figure 2C).
Similar dosage effects were observed when Wnt3a protein
was used in place of CHIR (Figure S2). Therefore, endogenous
WNT signaling, as exists in WT iPSCs, or a low level of exog-
enous WNT signal activation with CHIR in FDH iPSCs is




Figure 2. WNT Signaling Is Required to Maintain the Pluripotent State
(A)WT iPSCs or FDH iPSCs (clone 3.C.1) were cultured for 5 dayswith increasing doses of CHIR98014 (CHIR), and expression ofPOU5F1/OCT4 andNANOGwas
determined by qRT-PCR. See also Figure S2.
(B) Clone 3.C.1 requires low levels of WNT stimulation to maintain an optimal hPSC morphology. In the absence of CHIR, WT iPSCs exhibit a normal hPSC
morphology, whereas FDH-iPSCs fail to grow with the characteristic morphology associated with hPSCs. At CHIR concentrations of 20 nM, FDH iPSC colonies
most closely resembleWT iPSCs. At concentrations of 200 nM, both cell populations assume a cell morphology indicative of differentiation. Scale bar represents
500 mM.
(C) FDH iPSCs (Clone 3.C.4) were cultured for 5 days in the presence (left) or absence (right) of CHIR (20 nM), stained for the cell-surface markers SSEA4 and
TRA1-81, and analyzed by flow cytometry. Significantly higher cell-surface staining for these two pluripotency-associated markers is observed in the presence of
CHIR (70%) than in the absence of CHIR (21%).Additional characterization confirmed that FDH-iPSCs exhibit
properties associated with bona fide pluripotent stem cells,
including the characteristic morphology associated with human
embryonic stem cells (Figure 3A), and expression of pluripotency
markers, such as OCT4, NANOG (Figure 3B), TRA-1-81 (Fig-
ure 3C), and SSEA4 (Figure S3A). In addition, we confirmed their
pluripotency by directing them to differentiate via embryoid
bodies (EB) into cell populations of the three major germ layers:
endo-, ecto-, and mesoderm. EBs from FDH-iPSC clone 3.C.1
expressed genes indicative of definitive endoderm (DE,
SOX17, FOXA2, and CXCR4; Figures 3D, S3B, and S3C), meso-
derm (BRY/T, MESP1, and ACTC1; Figures 3E and S3D), and
ectoderm (PAX6, SOX1, and TUBB3; Figure 3F). Therefore, the
FDH-iPSCs retain their ability to differentiate into cell types
representative of the three major germ layers.
Surprisingly, FDH-iPSC clones isolated in the presence of
Wnt3a exhibited dramatically altered karyotypes, with cells
containing more than 60 chromosomes and other chromosomal
aberrations, including insertions, deletions, translocations, and
inversions (Figures 4A and S4A–S4C). Because the FDH fibro-Cell Reblasts were euploid (Figure 4B), the acquisition of aberrant
chromosome numbers likely occurred during reprogramming.
Importantly, iPSCs derived from WT fibroblasts (BJ) in the
presence of Wnt3a were karyotypically normal (Figure 4C), indi-
cating that changes in chromosome numbers upon reprog-
ramming are associated with ectopic WNT signaling only in a
PORCN-deficient context. Karyotypic abnormalities in Wnt3a-
derived FDH-iPSCs did not represent clonal expansions
because individual metaphase spreads from the same iPSC
line exhibited distinct chromosome numbers (Figures 4E and
S4A–S4C). Therefore, reprogramming of FDH fibroblasts (and
hence WNT-deficient cells) in the presence of Wnt3a is detri-
mental to genomic integrity.
Because purified WNT proteins are highly unstable (Dhamd-
here et al., 2014; Green et al., 2013), we reasoned that daily addi-
tion of Wnt3a protein may produce nonphysiological spikes in
WNT signaling activity that may contribute to this chromosomal
instability. Previous studies have linked aberrant WNT signaling
to chromosomal instability (Aoki et al., 2007; Fodde et al.,
2001; Hadjihannas and Behrens, 2006; Hadjihannas et al.,ports 9, 1770–1780, December 11, 2014 ª2014 The Authors 1773
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Figure 3. Characterization of a FDH-iPSC Clone
(A) A phase contrast image of a FDH-iPSC clone (3.C.1) derived in the presence of CHIR exhibits characteristics of human pluripotent stem cells. Note that, as
shown in Figure 4D, these cells have a normal number of chromosomes. Scale bar represents 500 mm.
(B) qRT-PCR confirms expression of the pluripotencymarkersNANOG andOCT4/POU5F1 at levels comparable to a human embryonic stem cell line (H1/WA01).
(C) Flow cytometry confirms presence of the cell-surface pluripotency markers TRA1-81 at levels comparable to those found on H1 cells.
(D–F) Upon differentiation via embryoid body (EB) formation, cells expressmarkers associated with endodermal (D), mesodermal (E), and ectodermal (F) lineages.
See also Figure S3.2006; Kaplan et al., 2001; Tighe et al., 2007). To circumvent this
problem, we isolated FDH-iPSC colonies from reprogrammed
cultures derived in the presence of CHIR, which can be carefully
dosed and is more stable over longer periods thanWnt3a protein
(Figure S4D). Importantly, iPSC clones isolated, expanded, and
maintained in the presence of low CHIR concentrations that do
not promote differentiation of hESCs exhibited normal chromo-
some numbers (Figures 4D, 4E, and S4C), indicating that a
continuous and low level of WNT signaling activity, as provided
by CHIR, is essential for the generation of euploid iPSC colonies
from PORCN mutant fibroblasts.
To gain a better understanding of the role of theWNT signaling
pathway during reprogramming, we perturbed the pathway us-
ing a number of manipulations. Addition of Wnt3a protein during
reprogramming significantly increased the number of AP+ col-
onies (Figure 5A), consistent with findings by other groups (Ho
et al., 2013; Marson et al., 2008; Zhang et al., 2014). IPSCs
derived from WT fibroblasts in the presence of Wnt3a displayed
all the hallmarks of bona fide iPSCs, including a normal karyo-
type of 46 chromosomes (Figure 4C), the characteristic cell
morphology of hPSCs (Figure S5A), and expression of the plurip-
otency markers OCT4, NANOG (Figure S5B), TRA-1-81 (Fig-
ure S5C), and SSEA4 (Figure S5D). In addition, these iPSCs
were pluripotent, as determined by their ability to differentiate
into endodermal (expression of FOXA2 and SOX17; Figure S5E
and CXCR4 (Figures S5E and S5F), ectodermal (expression of
PAX6, SOX1, andMAP2; Figure S5G), and mesodermal lineages
(expression of T (BRY), MESP1, and ACTC1; Figure S5H).1774 Cell Reports 9, 1770–1780, December 11, 2014 ª2014 The AutThe enhancement of AP+ colonies was particularly pro-
nounced in the absence of MYC (KOS versus KMOS; Fig-
ure 5A versus 5B). Likewise, addition of the GSK3 inhibitor BIO
increased the number of iPSC colonies (Figure 5A). Overexpres-
sion of constitutively active b-catenin (b-catenin 4A) increased
reprogramming efficiencies by 1.4-fold (Figure 5C), thus confirm-
ing the findings by several other groups, including the original
description of iPSC generation (Takahashi and Yamanaka,
2006). Addition of RSPO1, a WNT agonist and LGR4/5/6 ligand
(Carmon et al., 2011; de Lau et al., 2011; Ruffner et al., 2012),
sensitized cells to low levels of exogenously added Wnt3a (Fig-
ure 5D). In the absence of exogenous Wnt3a, RSPO1-treated
cells exhibited a subtle and reproducible increase in reprogram-
ming efficiency. Because RSPO1 itself fails to activate WNT/
b-catenin signaling and only acts to augment WNT signaling,
potentially through WNT receptor turnover by ZNRF3 (Hao
et al., 2012), this result is consistent with the model that an
endogenousWNT signaling pathway is present and is uncovered
by RSPO1.
Several recent publications examined at which stage WNT
signaling most significantly influenced the rate of reprogram-
ming. These studies reached opposite conclusions, with two
studies demonstrating that early WNT activation inhibited re-
programming rates (Aulicino et al., 2014; Ho et al., 2013)
and another study demonstrating that early WNT activation
stimulated reprogramming rates (Zhang et al., 2014). We do
not have an explanation for this discrepancy; however, our find-
ings strongly argue that WNT signaling not only enhanceshors
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Figure 4. Ectopic Wnt3a Stimulation Yields Karyotypically Abnormal iPSCs
(A) A FDH3-iPSC derived in the presence of exogenous Wn3a (clone 3.W.1) exhibits an abnormal chromosome number. Additional images of abnormal chro-
mosome spreads highlighting chromosomal anomalies, such as insertions, deletions, translocations, and inversions, are provided in the Supplemental Exper-
imental Procedures (Figure S4).
(B) FDH3 fibroblasts exhibit a normal karyotype.
(C) An iPSC derived from unaffected fibroblasts (BJ, ATCC CRL-2522) in the presence of Wnt3a is euploid. Additional characterization of this iPSC clone is
provided in the Supplemental Experimental Procedures (Figure S5).
(D) A FDH-iPSC (clone 3.C.1) derived in the presence of the GSK3 inhibitor CHIR98014 (CHIR) is euploid.
(E) Quantitation of chromosome numbers in FDH-iPSCs. Chromosome numbers were obtained by counting condensed chromosomes of metaphase-arrested
cells (for representative images, see the Supplemental Experimental Procedures and Figure S4C). The dashed linemarks 46 chromosomes. Like HEK293T (293T)
cells, FDH-iPSCs derived in the presence of exogenousWnt3a carried significantly increased numbers of chromosomes. The hESC line H1, BJ-iPSCs derived in
the presence ofWnt3a (K.W.1 and K.W.2), and FDH-iPSCs derived in the presence of CHIR (clones 3.C.1 and 3.C.2) have 46 chromosomes. Note that thismethod
to quantify chromosome numbers is only reliable in determining themaximum number of chromosomes; metaphase spreadswith less than 46 aremost likely due
to loss of chromosomes during the preparation of the samples.
See also Figure S4.reprogramming but is also required for reprogramming. In addi-
tion, in our system, which differs from the other studies in that it is
human and does not involve the use of secondary iPSCs, we find
that early activation of WNT signaling promotes reprogramming
rates, whereas late activation has no impact (Figure 5E). Treat-
ment with IWP during any stage of reprogramming diminishes
the number of AP+ colonies. We therefore speculate that WNT
signaling is required early to establish the pluripotent state.
In contrast to activation of WNT signaling, inhibition of the
WNT signaling pathway reduced reprogramming efficiencies.
Like IWP (Figures 1F and 5E), blocking WNT/b-catenin signaling
with IWR (Chen et al., 2009), which acts to stabilize AXIN (a
component of the b-catenin degradation complex), reduced re-
programming efficiencies (Figure 5F). Consistent with the effect
of IWR, overexpression of AXIN by lentiviral transductionCell Rereduced reprogramming efficiencies (Figure 5G). Treatment
with purifiedWnt5a, which antagonizesWNT/b-catenin signaling
(Ishitani et al., 2003;Mikels andNusse, 2006), also interferedwith
reprogramming (Figure 5H), indicating that this noncanonical
WNT signaling pathway blocks reprogramming. Therefore,
canonical, rather than noncanonical WNT signaling promotes
reprogramming.
Several studies have implicated the WNT receptor encoded
by the FZD7 gene to be critical to the maintenance of the plurip-
otent stem cell state (Fernandez et al., 2014; Melchior et al.,
2008). Furthermore, FZD7 is the most abundantly expressed
FZD gene (the mammalian genome encodes 10 FZD genes) in
hESCs (Fernandez et al., 2014). We therefore examined to
which extent knockdown of FZD7 expression affected reprog-
ramming rates. Lentiviral transduction of a FZD7-specific shortports 9, 1770–1780, December 11, 2014 ª2014 The Authors 1775
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Figure 5. Modulation of WNT Signaling Influences Reprogramming Efficiencies
(A) Wnt3a and the GSK3 inhibitor BIO increase KOS reprogramming of wild-type fibroblasts. Fibroblasts were reprogrammed with factors KOS alone or in the
presence of Wnt3a or the GSK3 inhibitor BIO. (Quantification represents mean number of AP+ colonies ± SD, normalized to untreated condition [CTL]; n = 7 for
CTL, n = 6 for Wnt3a, and n = 3 for BIO; *p% 0.05; ****p% 0.0001.)
(B) Wnt3a increases KMOS reprogramming of wild-type fibroblasts. Fibroblasts were reprogrammed with factors KMOS in the presence or absence of Wnt3a.
(Quantification represents mean number of AP+ colonies ± SD, normalized to untreated condition [CTL]; n = 23 for CTL and n = 6 for Wnt3a; **p% 0.01.)
(C) Overexpression (OE) of constitutively active b-catenin (b-catenin 4A) increases reprogramming efficiencies. Fibroblasts were reprogrammed with factors KOS
in the presence or absence of ß-catenin 4A OE. (Quantification represents mean number of AP+ colonies ± SD, normalized to untreated condition [no Wnt3a and
no RSPO1]; n = 13 for KOS, n = 3 for all other conditions; *p% 0.05.)
(D) RSPO1 sensitizes cells to low levels of Wnt3a. Fibroblasts were reprogrammed with factors KOS in the presence or absence of RSPO1 with increasing
concentrations of Wnt3a. (Quantification represents mean number of AP+ colonies ± SD, normalized to untreated condition [no Wnt3a and no RSPO1]; n = 13 for
KOS, n = 3 for all other conditions; p values are between corresponding Wnt3a concentrations ± RSPO1; ns, not significant [p value for 2.5 nM Wnt3a data
points = 0.061], *p% 0.05 [p value for 0 nM Wnt3a data points = 0.022], **p% 0.01.)
(E) Addition of Wnt3a increases AP+ colony numbers when added early during the reprogramming process, whereas addition of IWP reduces AP+ colony
numbers when added early or late. Fibroblasts were reprogrammed with factors KMOS. Wnt3a or IWP were added either early, late or continuously during
reprogramming, as indicated in the diagram. (Quantification represents mean number of AP+ colonies, normalized to untreated condition [CTL]; n = 3 for all
conditions.) CONT., continuous treatment with Wnt3a or IWP.
(F) The Tankyrase inhibitor IWR, which induces AXIN stabilization, reduces numbers of AP+ colonies. Fibroblasts were reprogrammedwith factors KOS or KMOS
in the presence or absence of IWR. (Quantification representsmean number of AP+ colonies ±SD, normalized to untreated KOS condition; n = 7 for KOS, n = 5 for
KOS+IWR, n = 13 for KMOS, and n = 3 for KMOS+IWR; **p% 0.01.)
(G) AXIN overexpression (OE) by lentiviral gene transduction reduces numbers of AP+ colonies. Fibroblasts were reprogrammed with factors KMOS in the
presence or absence of AXIN OE. (Quantification represents mean number of AP+ colonies ± SD, normalized to KMOS condition [CTL]; n = 23 for CTL and n = 9
for AXIN; **p% 0.01.)
(H) Treatment of reprogramming cultures with Wnt5a, which antagonizes WNT/b-catenin signaling, reduces numbers of AP+ colonies. Fibroblasts were re-
programmed with factors KOS or KMOS in the presence or absence of WNT5A. (Quantification represents mean number of AP+ colonies ± SD, normalized to
untreated KOS condition; n = 7 for KOS, n = 4 for KOS+Wnt5a, n = 23 for KMOS, and n = 4 for KMOS+Wnt5a; *p% 0.05, ***p% 0.001.)
(legend continued on next page)
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Figure 6. A Model Summarizing the Role of
WNT Signaling during the Reprogramming
Process
An endogenous WNT signaling loop is required for
acquisition of the pluripotent state and for the
expansion of iPSCs.hairpin RNA (shRNA) significantly reduced reprogramming rates
(Figure 5I), suggesting a potential role for FZD7 in reprogram-
ming. However, because an endogenous WNT-FZD signaling
loop is essential to the maintenance of the pluripotent state, it
is difficult to distinguish whether this negative effect of FZD7
knockdown is due to an effect on the reprogramming process
or maintenance and expansion of iPSCs. Nonetheless, these
WNT signal pathway perturbations provide strong evidence
that reprogramming requires an active endogenous WNT/
FZD7/b-catenin signal.
DISCUSSION
Here, we show that WNT signaling is required for the generation
of iPSCs from fibroblasts. Mutation of thePORCN gene or chem-
ical inhibition of this essential WNT processing enzyme potently
blocks iPSC generation, a blockade that is readily overcome
through the ectopic activation of the WNT/b-catenin signaling
pathway. This effect of WNT signaling can be attributed to two
possible, and not necessarily mutually exclusive, modes of ac-
tion (summarized in Figure 6). First, activation of WNT signaling
is a requisite step to convert a differentiated cell to an iPSC. Sec-
ond, continuousWNT signaling is required to promote expansion
of a single iPSC to an iPSC colony.
Our experiments, as well as studies by several other groups,
indicate that endogenous WNT signaling is required to maintain
the pluripotent state. Blocking endogenous WNT signaling with
PORCN inhibitors, such as IWP2, leads to a decrease in expres-(I) FZD7 knockdown (KD) by lentiviral transduction of a FZD7-specific shRNA reduces numbers of AP+ col
KMOS. Simultaneously, one set of cells was transduced with a lentiviral vector expressing a FZD7-specific
AP+ colonies ± SD, normalized to standard condition [CTL]; n = 13 for CTL and n = 8 for FZD7 knockdown
See also Figure S5.
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and a concomitant reduction in expres-
sion of the pluripotency regulators
NANOG and OCT4 (Fernandez et al.,
2014). Consistent with these observa-
tions, WNT signal activation is required
to generate iPSCs in which endogenous
WNT signaling is disrupted through
PORCN mutation or inhibition. Interest-
ingly, expression of pluripotency genes
is sensitive to the level of WNT signal acti-
vation in FDH-iPSCs, but not in wild-type
iPSCs, again consistent with the notion
that WNT signaling is required to maintain
expression of pluripotency components.
We also found that the WNT cofactorRSPO1, which augments WNT signaling activity, increases the
efficiency of reprogramming, suggesting that it uncovers an
endogenous WNT signaling activity necessary to promote the
reprogramming process. Together, these data support the
model that endogenous WNT signaling is required to maintain
pluripotency and consequently is essential to induce pluripo-
tency in fibroblasts.
Our experiments to address the timing requirement for WNT
signaling during reprogramming indicate that WNT signal activa-
tion is more critical during the early, rather than later, stages of
reprogramming, consistent with the results of others (Zhang
et al., 2014). However, other groups found that activation of
WNT signaling during early stages inhibits reprogramming,
whereas inhibition of WNT signaling during early stages pro-
motes reprogramming (Aulicino et al., 2014; Ho et al., 2013).
We currently do not have an explanation for this discrepancy.
However, it is important to stress that WNT signaling exhibits
distinct dosage effects, with low levels promoting the pluripotent
state, as discussed above, and high levels promoting mesendo-
dermal differentiation (Bakre et al., 2007; Davidson et al., 2012).
Treatment of undifferentiated human embryonic stem cells with
Wnt3a or a GSK3 inhibitor is an established method to direct
definitive endoderm differentiation (Brafman et al., 2013;
D’Amour et al., 2005; Kroon et al., 2008; Schulz et al., 2012).
Therefore, overstimulation of WNT signaling may drive pluripo-
tent stem cells into a mesendodermal lineage, which will lack
expression of pluripotency-associated genes and hence will
not be observed as iPSCs.onies. Fibroblasts were reprogrammed with factors
shRNA. (Quantification represents mean number of
, **p% 0.01.)
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The dosing ofWNT activity not only affects the choice between
self-renewal and differentiation but also influences genomic
integrity. In our reprogramming experiments we found that
ectopic WNT signal activation with Wnt3a promoted genomic
instability during reprogramming of PORCN mutant cells. The
association between ectopic WNT signaling and chromosomal
instability had been described previously but only in cells with
compromised genomic integrity, such as HCT116, SW480, and
HeLa cells (Hadjihannas and Behrens, 2006; Tighe et al.,
2007). Additional studies found that mouse embryonic stem cells
harboring mutations in the APC gene, a negative regulator of
WNT/b-catenin signaling, exhibit defects in chromosome segre-
gation, leading to highly variable chromosome numbers (Aoki
et al., 2007; Fodde et al., 2001; Kaplan et al., 2001). We extend
these studies by showing that cells harboringPORCNmutations,
and are consequently deficient for endogenous WNT protein
processing, are exquisitely sensitive to the level of exogenous
WNT signaling activity, with low and stable levels of WNT activa-
tion promoting iPSC generation without inducing genomic
instability. In contrast, higher levels of WNT signal activation
invariably yielded iPSCs with grossly aberrant chromosome
numbers. These findings on WNT’s effects on genomic integrity
serve as a cautionary note for the manipulation of WNT signaling
in the generation of cell populations intended for cell replace-
ment therapies because such genomic aberrationsmay promote
tumorigenesis. Our observation that ectopic WNT signaling pro-
motes chromosome missegregation and results in aneuploidy
may be related to WNT’s function as a locally acting polarity
ligand as previously demonstrated with bead-immobilized
WNT protein (Habib et al., 2013).
The process of reprogramming amature cell type to an embry-
onic stem cell-like state shares similarities with the processes of
cellular and tissue regeneration, especially as it occurs in verte-
brates with high regenerative potential, such as axolotl and ze-
brafish. As these organisms repair damaged tissues, such as
an amputated limb, a cell population, called the blastema, is
formed that orchestrates the regenerative process. Formation
of the blastema is thought to involve cellular dedifferentiation in
a manner that may resemble cellular reprogramming and the for-
mation of iPSCs.WNT genes are required for blastema formation
(Kawakami et al., 2006; Stoick-Cooper et al., 2007). In addition,
several studies have linked WNT signaling to tissue repair and
wound healing, including in skin and bone (Chen et al., 2007;
Chua et al., 2011; Fathke et al., 2006; Lim et al., 2013; Whyte
et al., 2013). It is tempting to speculate that the observed require-
ment for WNT signaling during the induction of the pluripotent
state represents a cell culture equivalent to these in vivo regen-
erative processes. Additional studies are needed to address the
extent to which WNT’s role in reprogramming resembles its role
in regenerative processes, such as wound healing.
EXPERIMENTAL PROCEDURES
Collection of FDH Patient Biopsies and Establishment of Fibroblast
Cultures
Skin punch biopsies were collected from consented individuals under protocol
H-21291 (‘‘Pathogenesis of Focal Dermal Hypoplasia or Goltz Syndrome and
Related Disorders and the Role Of PORCN in Focal Dermal Hypoplasia’’),
which was approved by the Institutional Review Board for Baylor College of1778 Cell Reports 9, 1770–1780, December 11, 2014 ª2014 The AutMedicine and Affiliated Hospitals. Fibroblast cultures were established as
described in the Supplemental Experimental Procedures.
Cells and Culture Conditions
Cells were cultured as described in the Supplemental Experimental Proce-
dures. HESC lines (H1/ WA01/NIH registration number 0043; H9/ WA09/NIH
registration number 0062; HUES 9/NIH registration number 0022) and iPSC
lines were cultured as described in Chen et al. (2011). Experiments involving
human embryonic and induced pluripotent stem cells were approved by the
UCSD Human Research Protections Program (Principal Investigator: Karl Wil-
lert, protocols #120799: ‘‘A model for focal dermal hypoplasia using human
induced pluripotent stem cells,’’ and #100210: ‘‘Role ofWnt signaling in human
ES cell proliferation and differentiation’’).
Plasmids, Recombinant Proteins, Small Molecules, and Antibodies
Sources of plasmids, small molecules, and antibodies are provided in the Sup-
plemental Experimental Procedures. WNT proteins were purified as previously
described (Willert, 2008). RSPO1 was purified as previously described (Wei
et al., 2007) with the modifications described in the Supplemental Experi-
mental Procedures.
Reprogramming and Differentiation Protocols
Details of the reprogramming protocols, quantitation of iPSC colonies, and dif-
ferentiation into EBs or specific lineages are provided in the Supplemental
Experimental Procedures.
Gene Expression Analysis
Gene expression was analyzed by quantitative (qRT-PCR) with the protocols
and primers provided in the Supplemental Experimental Procedures.
Flow Cytometry
Flow cytometry was performed in the UCSDHuman Embryonic StemCell Core
Facility with experimental details and antibodies provided in the Supplemental
Experimental Procedures.
Karyotyping
Karyotyping with G-banding was performed by Cell Line Genetics. Chromo-
some counts shown in Figures 4E and S4C were performed as described in
the Supplemental Experimental Procedures.
WNT Protein Detection
WNT5A protein was detected by immunoblotting of Blue Sepharose
precipitates of fibroblast-conditioned media, as shown in Figure S1D.
A detailed protocol is provided in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.10.049.
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